Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0228-3059 -
Package NDC
0228-3059-11 -
Application number
ANDA077302 -
SPL ID
a90e80bb-ff5a-4665-b0ad-66cca29c86d1 -
SPL set ID
c5c2d060-452c-4f76-ad93-2e41fd8f06c2 -
UNII
JJ768O327N -
UNII
O1ZPV620O4 -
UNII
G83415V073 -
UNII
6DPV8NK46S -
RxCUI
861221 -
RxCUI
861223 -
RxCUI
861225 -
RxCUI
861227 -
RxCUI
861232 -
RxCUI
861237
What the source publishes
- Labeler
- Actavis Pharma, Inc.
- Active ingredients
- Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
- DEXTROAMPHETAMINE SACCHARATE
- AMPHETAMINE ASPARTATE MONOHYDRATE
- DEXTROAMPHETAMINE SULFATE
- AMPHETAMINE SULFATE
Complete source data
{
"name": "Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate",
"splId": "a90e80bb-ff5a-4665-b0ad-66cca29c86d1",
"labels": [
{
"setId": "c5c2d060-452c-4f76-ad93-2e41fd8f06c2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5c2d060-452c-4f76-ad93-2e41fd8f06c2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5c2d060-452c-4f76-ad93-2e41fd8f06c2"
}
],
"routes": [
"ORAL"
],
"labeler": "Actavis Pharma, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3059-11)",
"package_ndc": "0228-3059-11",
"identifierStatus": "well-formed",
"marketing_start_date": "20120622"
}
],
"productId": "0228-3059_a90e80bb-ff5a-4665-b0ad-66cca29c86d1",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "0228-3059",
"deaSchedule": "CII",
"genericName": "Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DEXTROAMPHETAMINE SACCHARATE",
"strength": "2.5 mg/1"
},
{
"name": "AMPHETAMINE ASPARTATE MONOHYDRATE",
"strength": "2.5 mg/1"
},
{
"name": "DEXTROAMPHETAMINE SULFATE",
"strength": "2.5 mg/1"
},
{
"name": "AMPHETAMINE SULFATE",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA077302",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120622",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0302283059110",
"0302283064114",
"0302283063117"
],
"unii": [
"JJ768O327N",
"O1ZPV620O4",
"G83415V073",
"6DPV8NK46S"
],
"rxcui": [
"861221",
"861223",
"861225",
"861227",
"861232",
"861237"
],
"spl_set_id": [
"c5c2d060-452c-4f76-ad93-2e41fd8f06c2"
],
"manufacturer_name": [
"Actavis Pharma, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0228-3059_a90e80bb-ff5a-4665-b0ad-66cca29c86d1"